Rhenman & Partners Asset Management’s DexCom DXCM Stock Holding History

Rhenman & Partners Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Buy	+160,000	New	+$10.7M	1.02%	45
2025 Q3	–	Sell	-159,500	Closed	-$13.9M	–	94
2025 Q2	$13.9M	Buy	159,500 +4,500	+3%	+$353K	1.76%	22
2025 Q1	$10.6M	Buy	+155,000	New	+$12.6M	1.22%	31
2024 Q4	–	Sell	-87,000	Closed	-$5.83M	–	94
2024 Q3	$5.83M	Sell	87,000 -30,000	-26%	-$2.46M	0.47%	63
2024 Q2	$13.3M	Sell	117,000 -21,500	-16%	-$2.72M	1.27%	29
2024 Q1	$19.2M	Buy	138,500 +28,500	+26%	+$3.58M	1.82%	23
2023 Q4	$13.6M	Buy	110,000 +65,000	+144%	+$6.64M	1.36%	28
2023 Q3	$4.2M	Buy	+45,000	New	+$5.07M	0.45%	56
2018 Q1	–	Sell	-282,500	Closed	-$4.05M	–	94
2017 Q4	$4.05M	Sell	282,500 -197,500	-41%	-$2.57M	0.55%	63
2017 Q3	$5.87M	Buy	480,000 +62,480	+15%	+$1.1M	0.75%	53
2017 Q2	$7.63M	Buy	417,520 +189,920	+83%	+$3.51M	1.1%	35
2017 Q1	$4.82M	Sell	227,600 -111,600	-33%	-$2.18M	0.76%	51
2016 Q4	$5.06M	Buy	339,200 +79,200	+30%	+$1.4M	0.97%	38
2016 Q3	$5.7M	Buy	260,000 +40,000	+18%	+$890K	0.91%	39
2016 Q2	$4.36M	Sell	220,000 -80,000	-27%	-$1.36M	0.77%	51
2016 Q1	$5.09M	Sell	300,000 -120,000	-29%	-$2M	1.01%	38
2015 Q4	$8.6M	Buy	420,000 +84,000	+25%	+$1.75M	1.3%	32
2015 Q3	$7.21M	Sell	336,000 -32,000	-9%	-$714K	1.15%	36
2015 Q2	$7.36M	Buy	368,000 +60,000	+19%	+$1.05M	0.88%	34
2015 Q1	$4.8M	Buy	308,000 +52,000	+20%	+$786K	0.81%	45
2014 Q4	$3.52M	Sell	256,000 -168,000	-40%	-$2.06M	1.02%	33
2014 Q3	$4.24M	Buy	424,000 +24,000	+6%	+$245K	1.24%	29
2014 Q2	$3.97M	Buy	400,000 +84,848	+27%	+$752K	1.18%	26
2014 Q1	$3.26M	Buy	315,152 +7,152	+2%	+$73.9K	0.98%	35
2013 Q4	$2.73M	Buy	+308,000	New	+$2.44M	1.07%	39

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Rhenman & Partners Asset Management's DXCM Position: Q2 2026 in Review

Rhenman & Partners Asset Management opened a new position in DexCom (DXCM) in Q2 2026: 160,000 shares worth $10.8M. The stake represents 1.02% of the portfolio and ranks #45 among its holdings. This is a return to the name: Rhenman & Partners Asset Management previously reported a position in DXCM as recently as Q2 2025.

Rhenman & Partners Asset Management first reported a position in DXCM in Q4 2013 and has held it in 25 quarters since. The position peaked at $19.2M in Q1 2024. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Rhenman & Partners Asset Management held 160,000 shares of DexCom worth $10.8M as of Q2 2026.
DexCom was a new Rhenman & Partners Asset Management position in Q2 2026.
DexCom made up 1.02% of Rhenman & Partners Asset Management's portfolio in Q2 2026, its #45 holding.
Rhenman & Partners Asset Management first reported a position in DexCom in Q4 2013 and has held it in 25 quarters since.
Rhenman & Partners Asset Management's DexCom position peaked at $19.2M in Q1 2024.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.